Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTHF 4 Days Payable is 12,084.92 as of Mar. 2026, which is 644% above its 10-year median of 1,623.43. GuruFocus rates OPTHF with a GF Score™ of 4/100 and a GF Value™ of $0.14 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, Optimi Health ranks better than 96.87% on this metric.
The historical rank and industry rank for Optimi Health's Days Payable or its related term are showing as below:
OPTHF'
s Days Payable Range Over the Past 10 Years
Min: 714.85 Med: 1623.43 Max: 2532
Current: 1123.51
During the past 6 years, Optimi Health's highest Days Payable was 2532.00. The lowest was 714.85. And the median was 1623.43.
OPTHF's Days Payable is ranked better than 96.87% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs OPTHF: 1123.51
Optimi Health's Days Payable
increased
from Mar. 2025 (5,292.50) to Mar. 2026 (12,084.92).
It may suggest that Optimi Healthdelayed paying its suppliers.
Optimi Health Days Payable Related Terms
Optimi Health Days Payable Historical Data
* Premium members only.
The historical data trend for Optimi Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Optimi Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Optimi Health's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimi Health (OPTHF) has a Days Payable of 12,084.92 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Optimi Health and its competitors. This is 644% above median its historical median of 1,623.43. Over the past decade, Optimi Health's Days Payable has ranged from 714.85 to 2,532.00. According to the industry distribution chart, Optimi Health ranks #29 out of 927 companies in the Drug Manufacturers industry, placing it in the top 3.1%.
Is Optimi Health's Days Payable too high?
Optimi Health's current Days Payable of 12,084.92 is 644% above median its 10-year median of 1,623.43. Over the past 10 years, this metric has ranged from a low of 714.85 to a high of 2,532.00. The Drug Manufacturers industry median Days Payable is 90.38. Optimi Health's value of 12,084.92 is 13271.2% above this industry median. Based on the distribution chart, Optimi Health ranks #29 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Optimi Health has a GF Score™ of 4/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #29 out of 927 companies for Days Payable. This places Optimi Health in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Optimi Health's value of 12,084.92 is 13271.2% above this benchmark. Historically, Optimi Health's own Days Payable has ranged from 714.85 to 2,532.00 over the past decade. While the company's 10-year median is 1,623.43 vs. the industry median of 90.38, Optimi Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimi Health's current Days Payable of 12,084.92 is 13271.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Optimi Health and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current Days Payable is 12,084.92, which is 644% above median its own 10-year median of 1,623.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.14, compared to a current price of $0.24 — trading 68% above its estimated fair value. The current Days Payable is 12,084.92, which is 644% above median its 10-year median of 1,623.43 and 13271.2% above the Drug Manufacturers industry median of 90.38. Optimi Health's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Optimi Health (OPTHF), the current Days Payable is 12,084.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $0.24 is trading 68% above its estimated GF Value™ of $0.14.
GuruFocus considers Optimi Health to be Significantly Overvalued.
Key valuation signals for OPTHF:
Days Payable: 12,084.92 (644% above median its 10-year median of 1,623.43)
GF Value™: $0.14 vs. price of $0.24 (68% above fair value)
Industry Position: 13271.2% above the Drug Manufacturers median (#29 of 927)
No single metric tells the full story. See the OPTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
4GF Score
Get the complete analysis for OPTHF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTHF has been successfully added to your 
